Literature DB >> 18593188

Synthesis of quinolines from 3-formylchromone.

Andrey S Plaskon1, Sergey V Ryabukhin, Dmitriy M Volochnyuk, Konstantin S Gavrilenko, Alexander N Shivanyuk, Andrey A Tolmachev.   

Abstract

A facile and versatile procedure for the synthesis of 3-(2-hydroxybenzoyl)quinolines and 7H-chromeno[3,2-c]quinolin-7-ones was elaborated on the basis of TMSCl-mediated recyclization of 3-formylchromone with various anilines. Limitations and scope of this methodology were established, and a possible mechanism for the heterocyclizations was proposed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593188     DOI: 10.1021/jo800950y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  5 in total

1.  A facile tandem Michael addition/O-cyclization/elimination route to novel chromeno[3,2-c]pyridines.

Authors:  Remani Vasudevan Sumesh; Akilan Malathi; Raju Ranjith Kumar
Journal:  Mol Divers       Date:  2015-03-11       Impact factor: 2.943

2.  A simple and convenient synthesis of 3-salicyloylquinoline-4-carboxylic esters from chromone and isatin.

Authors:  Xuequan Wang; Zhixin Yang; Weihang Miu; Pingting Ye; Mengjiao Bai; Suyue Duan; Xianfu Shen
Journal:  RSC Adv       Date:  2019-11-12       Impact factor: 4.036

3.  Combinatorial synthesis of chemical building blocks 1. Azomethines.

Authors:  Sergey V Ryabukhin; Dmitriy M Panov; Andrey S Plaskon; Alexander Chuprina; Sergey E Pipko; Andrey A Tolmachev; Alexander N Shivanyuk
Journal:  Mol Divers       Date:  2012-10-30       Impact factor: 2.943

4.  Transition metal-free one-pot synthesis of substituted pyrroles by employing aza-Wittig reaction.

Authors:  Chetna Jadala; Budaganaboyina Prasad; A V G Prasanthi; Nagula Shankaraiah; Ahmed Kamal
Journal:  RSC Adv       Date:  2019-09-27       Impact factor: 4.036

Review 5.  Advancements in the synthesis of fused tetracyclic quinoline derivatives.

Authors:  Ramadan A Mekheimer; Mariam A Al-Sheikh; Hanadi Y Medrasi; Kamal U Sadek
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.